JP Morgan Chase
LUNG icon

JP Morgan Chase’s Pulmonx LUNG Stock Holding History

JP Morgan Chase’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99K Sell
2,250
-385,853
-99% -$532K ﹤0.01% 7159
2026
Q1 		$458K Sell
388,103
-38,676
-9% -$63.9K ﹤0.01% 5086
2025
Q4 		$943K Sell
426,779
-70,323
-14% -$132K ﹤0.01% 4653
2025
Q3 		$805K Sell
497,102
-94,739
-16% -$198K ﹤0.01% 4742
2025
Q2 		$1.53M Sell
591,841
-62,542
-10% -$247K ﹤0.01% 4108
2025
Q1 		$4.4M Sell
654,383
-114,047
-15% -$807K ﹤0.01% 3266
2024
Q4 		$5.22M Sell
768,430
-287,092
-27% -$1.89M ﹤0.01% 3300
2024
Q3 		$8.75M Buy
1,055,522
+25,002
+2% +$181K ﹤0.01% 2721
2024
Q2 		$6.53M Buy
1,030,520
+765,945
+290% +$5.89M ﹤0.01% 2829
2024
Q1 		$2.45M Buy
264,575
+212,312
+406% +$2.49M ﹤0.01% 3687
2023
Q4 		$666K Buy
52,263
+26,831
+106% +$279K ﹤0.01% 4607
2023
Q3 		$263K Sell
25,432
-3,988
-14% -$46.2K ﹤0.01% 4891
2023
Q2 		$386K Sell
29,420
-118,798
-80% -$1.45M ﹤0.01% 4655
2023
Q1 		$1.66M Buy
148,218
+90,404
+156% +$893K ﹤0.01% 3670
2022
Q4 		$487K Buy
57,814
+25,051
+76% +$238K ﹤0.01% 4542
2022
Q3 		$545K Buy
32,763
+1,026
+3% +$18.9K ﹤0.01% 4400
2022
Q2 		$467K Buy
31,737
+4,927
+18% +$101K ﹤0.01% 4606
2022
Q1 		$665K Sell
26,810
-24,794
-48% -$640K ﹤0.01% 4520
2021
Q4 		$1.66M Sell
51,604
-107,589
-68% -$3.93M ﹤0.01% 3998
2021
Q3 		$5.73M Buy
159,193
+146,960
+1,201% +$5.78M ﹤0.01% 2921
2021
Q2 		$540K Sell
12,233
-102,318
-89% -$4.46M ﹤0.01% 4643
2021
Q1 		$5.24M Buy
114,551
+86,886
+314% +$4.98M ﹤0.01% 2935
2020
Q4 		$1.91M Buy
+27,665
New +$1.35M ﹤0.01% 3503

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

JP Morgan Chase's LUNG Position: Q2 2026 in Review

JP Morgan Chase reduced its Pulmonx (LUNG) stake by 99% in Q2 2026, selling an estimated $532K and leaving 2,250 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #7159.

JP Morgan Chase first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $8.75M in Q3 2024. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • JP Morgan Chase held 2,250 shares of Pulmonx worth $2.99K as of Q2 2026.
  • JP Morgan Chase sold 385,853 Pulmonx shares in Q2 2026, an estimated $532K.
  • Pulmonx made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7159 holding.
  • JP Morgan Chase first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • JP Morgan Chase's Pulmonx position peaked at $8.75M in Q3 2024.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.